MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 15, 2004; DOI: 10.1124/mol.104.005496


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
mol.104.005496v1
66/6/1440    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, S. P
Right arrow Articles by Corton, J C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, S. P
Right arrow Articles by Corton, J C.


Received for publication July 28, 2004.
Revised September 9, 2004.
Accepted for publication September 14, 2004.

Overlapping Transcriptional Programs Regulated by the Nuclear Receptors Peroxisome Proliferator-Activated Receptor {alpha}, Retinoid X Receptor and Liver X Receptor in Mouse Liver

Steven P Anderson 1, Corrie Dunn 2, Ashley Laughter 2, Lawrence Yoon 1, Cynthia Swanson 2, Thomas M Stulnig 3, Knut R Steffensen 3, Roshantha AS Chandraratna 4, Jan-Ake Gustafsson 3, J Christopher Corton 5*

1 GSK 2 CIIT 3 Karolinska Institute 4 Allergan 5 ToxicoGenomics

* Address correspondence to: E-mail: ccorton{at}msn.com

Abstract

Lipid homeostasis is controlled in part by the nuclear receptors peroxisome proliferator (PP)-activated receptor {alpha} (PPAR{alpha}) and liver X receptor (LXR) through regulation of genes involved in fatty acid and cholesterol metabolism. Exposure to agonists of retinoid X receptor (RXR), the obligate heterodimer partner of PPAR{alpha} and LXR results in responses that partially overlap with those of PP. To better understand the gene networks regulated by these NR, transcript profiles were generated from the livers of wild-type and PPAR{alpha}null mice exposed to the RXR pan-agonist AGN194,204 or the PPAR pan-agonist, WY-14,643 (WY) and compared to the profiles from the livers of wild-type and LXR[alpha]/LXR{beta}-null mice after exposure to the LXR agonist T0901317. All 218 WY-regulated genes altered in wild-type mice required PPAR{alpha}. Remarkably, ~80% of genes regulated by AGN194,204 required PPAR{alpha} including cell-cycle genes, consistent with AGN-induced hepatocyte proliferation having both PPAR[alpha]-dependent and -independent components. Overlaps of ~31-62% in the transcript profiles of WY, AGN194,204 and T0901317 required PPAR[alpha] and LXR[alpha]/LXR{beta} for statistical significance. Out of the 50 overlapping genes regulated by T0901317 and WY, all but one were regulated in a similar direction. These results 1) identify new transcriptional targets of PPAR{alpha} and RXR important in regulating lipid metabolism and liver homeostasis, 2) illustrate the importance of PPAR{alpha} in regulation of gene expression by a prototypical PP and by an RXR agonist and 3) provide support for an axis of PPAR{alpha}RXR-LXR in which agonists for each nuclear receptor regulate an overlapping set of genes in the mouse liver.


Key words: PPARs, Pharmacogenomic analyses, Regulation of gene expression, Regulation - transcriptional, Toxicant-induced gene express, Cholesterol metabolism/lipoproteins





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics